Ghrelin-attenuated cognitive dysfunction in streptozotocin-induced diabetic rats

Area of Science:

• Neuroscience
• Endocrinology
• Molecular Biology

Background:

• Diabetic encephalopathy presents with cognitive and behavioral deficits, but its underlying mechanisms remain unclear.
• Ghrelin, a hormone, is being investigated for its potential therapeutic effects on cognitive dysfunction.

Purpose of the Study:

• To investigate the pathogenesis of diabetic encephalopathy.
• To explore the mechanisms by which ghrelin ameliorates cognitive dysfunction in diabetic rats.

Main Methods:

• Streptozotocin-induced diabetic rat models were used, with groups receiving ghrelin or ghrelin with D-lys-3-GHRP-6 treatment.
• Cognitive function was assessed using the Morris water maze test.
• Hippocampal expression of proteins (BDNF, CREB, p-CREB, p-ERK1/2, caspase-3, Bcl-xl) and mRNA was analyzed via immunohistochemistry and RT-PCR.
• Neuronal apoptosis was quantified using TUNEL assays.

Main Results:

• Ghrelin treatment significantly improved learning and memory in diabetic rats.
• Ghrelin increased the expression of Bcl-xl, BDNF, CREB, p-CREB, and p-ERK1/2 in the hippocampus.
• A notable decrease in hippocampal neuronal apoptosis was observed in the ghrelin-treated group.

Conclusions:

• Changes in BDNF, CREB, and hippocampal neuronal apoptosis are implicated in the pathogenesis of diabetic encephalopathy.
• Ghrelin enhances cognitive function in diabetic rats by upregulating BDNF and CREB expression and reducing neuronal apoptosis.
• The therapeutic effects of ghrelin involve the ghrelin receptor (GHSR-1a) and the ERK1/2 pathway.